Clinical trial

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

NCT05868057

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-05-23

PhasePHASE1

Study timeline

Study start (actual)2023-05-23Date precision: day

Registry last updated2023-12-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproductionunresolved

Interventions

SHR7280 tabletsDRUG

SHR7280 dry suspensionDRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05868057 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.